OmniAb | Investor Presentation Deck | 39 slides · page 27 of 39
The footer contains a dense list of specific patent application numbers as supporting evidence.
Pitch deck · unfair_advantage · show_traction · overcrowded density
Slide locked Sign in to view
Slide schematic 7/7
callout 2/2 chart 1/1 disclaimer 1/1 list 1/1 title 2/2
Components 7
primary primary bar-vertical disclaimer bullet action-title headline
Tools 2
AIDA Model slide · 70%
The slide presents a clear attention-grabbing headline, followed by a list of bullet points that provide interest and desire, and a call-to-action is implied.
Call to action slide · 70%The callout 'Over 300 patents issued worldwide' and '>65 patent filings by our partners claiming an OmniAb-derived antibody as primary invention, with expiries up to 2041' serve as a call to action for investors.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.